News

A Durham man with stage four lung cancer credits a Duke clinical trial for giving him his life back. The trial is funded by ...
Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, ...
Lung cancer is the number one cancer killer in the world. Biomarker testing improves outcomes in stage IV non-small cell lung cancer (NSCLC), however its ...
VQ Biomedical, spun out of Duke University, has developed a novel, minimally invasive catheter designed to deliver oxygen directly to the bloodstream. The catheter bypasses the lungs, giving ARDS ...
Researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy -- opening a new path for lung ...
BeiGene has made the decision to end the clinical development program for ociperlimab (BGB-A1217) for the treatment of non-small cell lung cancer ...
Findings from an earlier trial of the Eli Lilly drug, called lepodisiran, showed the drug was safe. The latest study, a Phase 2 clinical trial funded by Lilly, included 320 people. One injection ...
Advanced lung cancer, which has spread (metastasized) from the primary tumor to distant organs, is associated with lower survival rates. That's because lung cancer becomes more difficult to treat as ...
An Apple TV+ free trial is the best way to try out one of the best streaming services. While it was once regarded as smaller than the likes of Netflix and Prime Video, Apple TV+ has seen a big ...
A panel of Brazil Supreme Court justices on Wednesday unanimously accepted charges against former President Jair Bolsonaro over an alleged attempt to stay in office after his 2022 election defeat, and ...